 Lisa Brenner
Concepts (478)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 115 | 2024 | 1213 | 19.750 |
Why?
| | Suicide | 50 | 2023 | 500 | 12.900 |
Why?
| | Brain Injuries, Traumatic | 26 | 2023 | 318 | 9.340 |
Why?
| | Brain Injuries | 42 | 2022 | 484 | 8.920 |
Why?
| | Military Personnel | 35 | 2024 | 529 | 7.100 |
Why?
| | Stress Disorders, Post-Traumatic | 35 | 2023 | 765 | 6.700 |
Why?
| | Brain Concussion | 16 | 2023 | 470 | 4.490 |
Why?
| | Suicidal Ideation | 28 | 2023 | 400 | 4.370 |
Why?
| | Suicide, Attempted | 23 | 2023 | 316 | 4.310 |
Why?
| | United States Department of Veterans Affairs | 33 | 2024 | 555 | 3.610 |
Why?
| | Veterans Health | 13 | 2024 | 167 | 3.150 |
Why?
| | United States | 91 | 2024 | 12557 | 2.830 |
Why?
| | Microbiota | 10 | 2023 | 656 | 2.630 |
Why?
| | Post-Concussion Syndrome | 8 | 2019 | 137 | 2.400 |
Why?
| | Mental Disorders | 16 | 2020 | 939 | 2.400 |
Why?
| | Mental Health | 16 | 2023 | 568 | 2.380 |
Why?
| | Humans | 210 | 2024 | 119032 | 2.170 |
Why?
| | Iraq War, 2003-2011 | 18 | 2024 | 151 | 2.150 |
Why?
| | Self-Injurious Behavior | 6 | 2020 | 120 | 2.050 |
Why?
| | Gastrointestinal Microbiome | 7 | 2023 | 548 | 2.010 |
Why?
| | Adult | 93 | 2023 | 31525 | 1.730 |
Why?
| | Occupational Therapy | 2 | 2023 | 73 | 1.660 |
Why?
| | Psychological Trauma | 3 | 2022 | 55 | 1.650 |
Why?
| | Male | 109 | 2024 | 57818 | 1.570 |
Why?
| | Middle Aged | 78 | 2023 | 27627 | 1.550 |
Why?
| | Health Personnel | 3 | 2021 | 588 | 1.520 |
Why?
| | Female | 112 | 2024 | 61588 | 1.500 |
Why?
| | Afghan Campaign 2001- | 15 | 2022 | 161 | 1.500 |
Why?
| | Brain Injury, Chronic | 4 | 2016 | 24 | 1.500 |
Why?
| | Blast Injuries | 6 | 2012 | 42 | 1.350 |
Why?
| | Sleep Wake Disorders | 5 | 2022 | 241 | 1.350 |
Why?
| | Social Determinants of Health | 2 | 2023 | 129 | 1.350 |
Why?
| | Surveys and Questionnaires | 20 | 2021 | 4709 | 1.320 |
Why?
| | Depressive Disorder, Major | 7 | 2022 | 303 | 1.280 |
Why?
| | Psychometrics | 10 | 2022 | 631 | 1.270 |
Why?
| | Firearms | 7 | 2023 | 281 | 1.260 |
Why?
| | Mental Health Services | 8 | 2020 | 331 | 1.160 |
Why?
| | Health Promotion | 5 | 2019 | 691 | 1.080 |
Why?
| | Hyperbaric Oxygenation | 3 | 2015 | 39 | 1.080 |
Why?
| | Pandemics | 5 | 2023 | 1355 | 1.050 |
Why?
| | Aftercare | 3 | 2021 | 194 | 1.020 |
Why?
| | Violence | 5 | 2023 | 218 | 1.010 |
Why?
| | Depressive Disorder | 4 | 2018 | 333 | 0.990 |
Why?
| | Severity of Illness Index | 14 | 2021 | 2674 | 0.970 |
Why?
| | Health Services Accessibility | 5 | 2020 | 781 | 0.960 |
Why?
| | Toxoplasmosis | 6 | 2024 | 31 | 0.960 |
Why?
| | Young Adult | 36 | 2023 | 10799 | 0.950 |
Why?
| | Aged | 39 | 2024 | 19661 | 0.950 |
Why?
| | Cross-Sectional Studies | 19 | 2024 | 4552 | 0.900 |
Why?
| | Substance-Related Disorders | 5 | 2023 | 971 | 0.880 |
Why?
| | Physical Therapy Specialty | 1 | 2023 | 33 | 0.870 |
Why?
| | Head Injuries, Closed | 1 | 2022 | 55 | 0.860 |
Why?
| | Evidence-Based Medicine | 3 | 2023 | 693 | 0.840 |
Why?
| | Patient Discharge | 5 | 2021 | 794 | 0.830 |
Why?
| | Drug Overdose | 2 | 2023 | 294 | 0.830 |
Why?
| | Toxoplasma | 5 | 2024 | 34 | 0.820 |
Why?
| | Personality Assessment | 4 | 2017 | 78 | 0.820 |
Why?
| | Cohort Studies | 16 | 2021 | 5117 | 0.800 |
Why?
| | Occupational Diseases | 2 | 2020 | 136 | 0.790 |
Why?
| | Longitudinal Studies | 13 | 2024 | 2513 | 0.780 |
Why?
| | Mass Screening | 7 | 2021 | 1052 | 0.780 |
Why?
| | Stroke Rehabilitation | 1 | 2021 | 34 | 0.770 |
Why?
| | Adaptation, Psychological | 7 | 2018 | 557 | 0.750 |
Why?
| | Spinal Cord Injuries | 2 | 2022 | 184 | 0.750 |
Why?
| | Models, Psychological | 1 | 2022 | 298 | 0.730 |
Why?
| | Dysbiosis | 2 | 2018 | 147 | 0.720 |
Why?
| | Disability Evaluation | 6 | 2019 | 280 | 0.720 |
Why?
| | Retrospective Studies | 18 | 2023 | 12990 | 0.680 |
Why?
| | Risk Factors | 28 | 2024 | 9003 | 0.670 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 8 | 0.660 |
Why?
| | Safety | 2 | 2020 | 304 | 0.660 |
Why?
| | Pets | 1 | 2018 | 21 | 0.660 |
Why?
| | Parkinson Disease | 1 | 2022 | 334 | 0.650 |
Why?
| | Death Certificates | 2 | 2023 | 28 | 0.650 |
Why?
| | Psychotherapy | 2 | 2017 | 177 | 0.650 |
Why?
| | Hope | 1 | 2018 | 13 | 0.640 |
Why?
| | Sense of Coherence | 1 | 2018 | 14 | 0.640 |
Why?
| | Mobile Applications | 1 | 2020 | 147 | 0.640 |
Why?
| | Child Development | 1 | 2022 | 410 | 0.640 |
Why?
| | Triage | 1 | 2020 | 203 | 0.620 |
Why?
| | Neuropsychological Tests | 7 | 2020 | 1032 | 0.620 |
Why?
| | Hospitals, Veterans | 7 | 2022 | 246 | 0.610 |
Why?
| | Wounds, Gunshot | 4 | 2020 | 176 | 0.610 |
Why?
| | Child Abuse | 1 | 2022 | 466 | 0.600 |
Why?
| | Drug Packaging | 1 | 2017 | 44 | 0.600 |
Why?
| | Risk | 5 | 2023 | 854 | 0.590 |
Why?
| | Psychotherapy, Group | 1 | 2017 | 61 | 0.590 |
Why?
| | Probiotics | 1 | 2017 | 49 | 0.580 |
Why?
| | Inflammation | 7 | 2022 | 2571 | 0.580 |
Why?
| | Executive Function | 4 | 2017 | 391 | 0.580 |
Why?
| | Patient Care Team | 3 | 2024 | 522 | 0.570 |
Why?
| | Risk Assessment | 15 | 2019 | 3057 | 0.570 |
Why?
| | Home Care Services | 1 | 2019 | 217 | 0.570 |
Why?
| | Outpatients | 2 | 2023 | 325 | 0.570 |
Why?
| | Feasibility Studies | 5 | 2021 | 749 | 0.560 |
Why?
| | Protective Factors | 2 | 2015 | 92 | 0.560 |
Why?
| | Cognition Disorders | 3 | 2014 | 529 | 0.560 |
Why?
| | Problem Solving | 1 | 2017 | 145 | 0.560 |
Why?
| | Postural Balance | 1 | 2018 | 184 | 0.560 |
Why?
| | Hospitalization | 5 | 2019 | 1785 | 0.560 |
Why?
| | Headache | 3 | 2022 | 128 | 0.540 |
Why?
| | Cause of Death | 2 | 2023 | 380 | 0.540 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 348 | 0.510 |
Why?
| | Coronavirus Infections | 1 | 2020 | 339 | 0.510 |
Why?
| | Self Report | 5 | 2017 | 699 | 0.500 |
Why?
| | Quality Improvement | 2 | 2020 | 963 | 0.490 |
Why?
| | Combat Disorders | 2 | 2017 | 34 | 0.490 |
Why?
| | Afghanistan | 3 | 2024 | 108 | 0.490 |
Why?
| | Qualitative Research | 8 | 2020 | 953 | 0.480 |
Why?
| | Comorbidity | 9 | 2022 | 1527 | 0.470 |
Why?
| | Case-Control Studies | 8 | 2022 | 3173 | 0.470 |
Why?
| | Neuropsychology | 2 | 2011 | 31 | 0.460 |
Why?
| | Disabled Persons | 2 | 2012 | 147 | 0.460 |
Why?
| | Health Planning | 1 | 2013 | 46 | 0.460 |
Why?
| | Hypertension | 1 | 2022 | 1203 | 0.460 |
Why?
| | Inpatients | 3 | 2014 | 389 | 0.450 |
Why?
| | Emotions | 1 | 2018 | 495 | 0.450 |
Why?
| | Iraq | 2 | 2024 | 82 | 0.450 |
Why?
| | Risk Management | 1 | 2014 | 90 | 0.450 |
Why?
| | Anxiety Disorders | 1 | 2016 | 309 | 0.440 |
Why?
| | Athletic Injuries | 1 | 2019 | 495 | 0.440 |
Why?
| | Medication Adherence | 1 | 2017 | 556 | 0.430 |
Why?
| | Quality of Life | 5 | 2019 | 2369 | 0.430 |
Why?
| | Trauma Severity Indices | 5 | 2019 | 127 | 0.430 |
Why?
| | Adolescent | 16 | 2023 | 18483 | 0.420 |
Why?
| | Interpersonal Relations | 1 | 2015 | 345 | 0.420 |
Why?
| | Psychiatric Status Rating Scales | 6 | 2018 | 499 | 0.420 |
Why?
| | Telemedicine | 1 | 2020 | 668 | 0.420 |
Why?
| | Stress, Physiological | 1 | 2015 | 415 | 0.410 |
Why?
| | Attitude of Health Personnel | 2 | 2016 | 993 | 0.410 |
Why?
| | Colorado | 6 | 2024 | 4196 | 0.410 |
Why?
| | Aged, 80 and over | 7 | 2021 | 6562 | 0.400 |
Why?
| | Ambulatory Care | 3 | 2018 | 482 | 0.400 |
Why?
| | Antibodies, Protozoan | 4 | 2024 | 28 | 0.400 |
Why?
| | Impulsive Behavior | 3 | 2018 | 105 | 0.380 |
Why?
| | Post-Traumatic Headache | 2 | 2020 | 4 | 0.380 |
Why?
| | Socioeconomic Factors | 6 | 2023 | 1129 | 0.380 |
Why?
| | Bayes Theorem | 2 | 2022 | 344 | 0.380 |
Why?
| | Wounds and Injuries | 1 | 2018 | 772 | 0.370 |
Why?
| | Sex Offenses | 2 | 2023 | 148 | 0.370 |
Why?
| | Reproducibility of Results | 9 | 2022 | 2874 | 0.370 |
Why?
| | Terminology as Topic | 1 | 2011 | 211 | 0.360 |
Why?
| | Depression | 3 | 2018 | 1137 | 0.350 |
Why?
| | Prevalence | 8 | 2022 | 2326 | 0.350 |
Why?
| | Diagnostic Imaging | 2 | 2011 | 294 | 0.340 |
Why?
| | Dizziness | 2 | 2019 | 70 | 0.330 |
Why?
| | Multiple Trauma | 1 | 2009 | 97 | 0.330 |
Why?
| | Amish | 2 | 2019 | 8 | 0.330 |
Why?
| | Quality of Health Care | 1 | 2013 | 586 | 0.330 |
Why?
| | Cognitive Dysfunction | 1 | 2013 | 301 | 0.330 |
Why?
| | Housing | 2 | 2020 | 123 | 0.330 |
Why?
| | Feces | 2 | 2023 | 396 | 0.330 |
Why?
| | Stress, Psychological | 2 | 2020 | 976 | 0.330 |
Why?
| | Intention | 1 | 2009 | 142 | 0.320 |
Why?
| | Kynurenine | 3 | 2018 | 81 | 0.310 |
Why?
| | Public Health | 4 | 2021 | 450 | 0.300 |
Why?
| | Neuropsychiatry | 2 | 2020 | 15 | 0.300 |
Why?
| | Patient Acceptance of Health Care | 2 | 2014 | 687 | 0.290 |
Why?
| | Health Behavior | 1 | 2012 | 720 | 0.290 |
Why?
| | Emergency Service, Hospital | 6 | 2020 | 1864 | 0.290 |
Why?
| | Environment, Controlled | 2 | 2016 | 20 | 0.280 |
Why?
| | Follow-Up Studies | 5 | 2022 | 4596 | 0.280 |
Why?
| | Recovery of Function | 4 | 2019 | 604 | 0.280 |
Why?
| | Immunoglobulin G | 4 | 2024 | 788 | 0.270 |
Why?
| | Treatment Outcome | 10 | 2022 | 9346 | 0.270 |
Why?
| | Time Factors | 6 | 2019 | 6414 | 0.270 |
Why?
| | Motivation | 1 | 2009 | 506 | 0.260 |
Why?
| | Social Support | 4 | 2015 | 542 | 0.260 |
Why?
| | Affect | 2 | 2018 | 240 | 0.260 |
Why?
| | Prospective Studies | 9 | 2022 | 6477 | 0.260 |
Why?
| | Complementary Therapies | 2 | 2016 | 71 | 0.250 |
Why?
| | Lomustine | 1 | 2024 | 14 | 0.250 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1795 | 0.240 |
Why?
| | Sex Distribution | 2 | 2023 | 351 | 0.230 |
Why?
| | Irritable Bowel Syndrome | 1 | 2023 | 29 | 0.230 |
Why?
| | Global Burden of Disease | 1 | 2023 | 15 | 0.230 |
Why?
| | Clinical Protocols | 2 | 2015 | 238 | 0.230 |
Why?
| | Antidepressive Agents | 2 | 2022 | 189 | 0.230 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2020 | 514 | 0.230 |
Why?
| | Prednisone | 1 | 2024 | 235 | 0.220 |
Why?
| | Psychiatric Department, Hospital | 2 | 2014 | 18 | 0.220 |
Why?
| | Abruptio Placentae | 1 | 2022 | 4 | 0.220 |
Why?
| | Interview, Psychological | 2 | 2015 | 93 | 0.220 |
Why?
| | Factor Analysis, Statistical | 3 | 2018 | 270 | 0.220 |
Why?
| | Aggression | 4 | 2021 | 184 | 0.220 |
Why?
| | Hotlines | 3 | 2023 | 25 | 0.210 |
Why?
| | Ohio | 1 | 2022 | 141 | 0.210 |
Why?
| | Pharmacogenomic Testing | 1 | 2022 | 54 | 0.210 |
Why?
| | Inappropriate Prescribing | 1 | 2022 | 52 | 0.210 |
Why?
| | Incidence | 6 | 2019 | 2424 | 0.210 |
Why?
| | Logistic Models | 6 | 2019 | 1901 | 0.200 |
Why?
| | Ethanol | 2 | 2023 | 575 | 0.200 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 164 | 0.200 |
Why?
| | Observational Studies as Topic | 1 | 2022 | 89 | 0.200 |
Why?
| | Frailty | 1 | 2024 | 116 | 0.200 |
Why?
| | Subacute Care | 1 | 2022 | 74 | 0.200 |
Why?
| | Schizophrenia | 2 | 2016 | 501 | 0.200 |
Why?
| | Policy | 1 | 2022 | 133 | 0.200 |
Why?
| | HIV Infections | 1 | 2015 | 2461 | 0.200 |
Why?
| | Hepatic Encephalopathy | 1 | 2021 | 22 | 0.200 |
Why?
| | Cost of Illness | 1 | 2023 | 258 | 0.200 |
Why?
| | Drug Interactions | 1 | 2022 | 352 | 0.190 |
Why?
| | Skin | 2 | 2023 | 657 | 0.190 |
Why?
| | Skilled Nursing Facilities | 1 | 2022 | 122 | 0.190 |
Why?
| | Anger | 3 | 2021 | 59 | 0.190 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2021 | 62 | 0.190 |
Why?
| | Porphyromonas gingivalis | 1 | 2020 | 15 | 0.180 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2016 | 239 | 0.180 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 9 | 0.180 |
Why?
| | Hyperacusis | 1 | 2019 | 8 | 0.180 |
Why?
| | Photophobia | 1 | 2019 | 10 | 0.180 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 56 | 0.180 |
Why?
| | Hypesthesia | 1 | 2019 | 17 | 0.180 |
Why?
| | Environment Design | 2 | 2016 | 22 | 0.180 |
Why?
| | Vitamin D Deficiency | 1 | 2021 | 162 | 0.180 |
Why?
| | Periodontitis | 1 | 2020 | 42 | 0.180 |
Why?
| | Morals | 1 | 2020 | 67 | 0.180 |
Why?
| | Survival Analysis | 3 | 2011 | 1267 | 0.180 |
Why?
| | Health Services Needs and Demand | 1 | 2021 | 254 | 0.180 |
Why?
| | Paresis | 1 | 2019 | 31 | 0.170 |
Why?
| | Arm Injuries | 1 | 2019 | 24 | 0.170 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2023 | 290 | 0.170 |
Why?
| | Tryptophan | 2 | 2018 | 139 | 0.170 |
Why?
| | Sleep | 2 | 2022 | 660 | 0.170 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 18 | 0.170 |
Why?
| | Delirium | 2 | 2011 | 70 | 0.170 |
Why?
| | Cross-Over Studies | 2 | 2018 | 456 | 0.170 |
Why?
| | Premature Birth | 1 | 2022 | 284 | 0.170 |
Why?
| | Fatigue | 2 | 2018 | 297 | 0.170 |
Why?
| | Environmental Microbiology | 1 | 2019 | 41 | 0.170 |
Why?
| | Medical Staff, Hospital | 1 | 2019 | 76 | 0.170 |
Why?
| | Odds Ratio | 5 | 2016 | 996 | 0.170 |
Why?
| | Liver Cirrhosis | 1 | 2021 | 245 | 0.170 |
Why?
| | Occupational Injuries | 1 | 2019 | 50 | 0.170 |
Why?
| | Patient-Centered Care | 1 | 2024 | 497 | 0.160 |
Why?
| | Women's Health | 1 | 2021 | 274 | 0.160 |
Why?
| | Arm | 1 | 2019 | 106 | 0.160 |
Why?
| | Diet | 2 | 2023 | 1155 | 0.160 |
Why?
| | Psychotherapy, Brief | 1 | 2018 | 32 | 0.160 |
Why?
| | Food Supply | 1 | 2019 | 64 | 0.160 |
Why?
| | Pilot Projects | 4 | 2017 | 1420 | 0.160 |
Why?
| | Adiponectin | 1 | 2020 | 226 | 0.160 |
Why?
| | Health Services Research | 1 | 2021 | 385 | 0.160 |
Why?
| | Phenylalanine | 1 | 2018 | 66 | 0.160 |
Why?
| | Dogs | 1 | 2018 | 371 | 0.150 |
Why?
| | Neopterin | 1 | 2017 | 8 | 0.150 |
Why?
| | Tyrosine | 1 | 2018 | 233 | 0.150 |
Why?
| | Prebiotics | 1 | 2017 | 24 | 0.150 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 275 | 0.150 |
Why?
| | Age Factors | 5 | 2019 | 2995 | 0.150 |
Why?
| | Confidence Intervals | 3 | 2016 | 324 | 0.150 |
Why?
| | Program Evaluation | 2 | 2019 | 845 | 0.150 |
Why?
| | Disease Models, Animal | 2 | 2017 | 3730 | 0.150 |
Why?
| | Gliadin | 1 | 2016 | 12 | 0.150 |
Why?
| | Databases, Factual | 1 | 2022 | 1231 | 0.150 |
Why?
| | Rural Population | 1 | 2020 | 452 | 0.140 |
Why?
| | Amygdala | 2 | 2017 | 175 | 0.140 |
Why?
| | Patient Selection | 1 | 2020 | 675 | 0.140 |
Why?
| | Emergency Medical Services | 1 | 2023 | 589 | 0.140 |
Why?
| | Physical Therapy Modalities | 1 | 2019 | 274 | 0.140 |
Why?
| | Housing, Animal | 1 | 2016 | 46 | 0.140 |
Why?
| | Nervous System Diseases | 1 | 2019 | 261 | 0.140 |
Why?
| | Perception | 2 | 2019 | 314 | 0.140 |
Why?
| | Social Work, Psychiatric | 1 | 2015 | 4 | 0.140 |
Why?
| | Community Mental Health Centers | 1 | 2015 | 14 | 0.140 |
Why?
| | Immunomodulation | 1 | 2016 | 89 | 0.140 |
Why?
| | Obesity | 2 | 2019 | 2751 | 0.140 |
Why?
| | Actigraphy | 1 | 2016 | 80 | 0.130 |
Why?
| | Neuroimaging | 2 | 2017 | 256 | 0.130 |
Why?
| | Alcoholism | 1 | 2022 | 717 | 0.130 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 793 | 0.130 |
Why?
| | Counseling | 2 | 2023 | 353 | 0.130 |
Why?
| | Medical Records | 1 | 2016 | 163 | 0.130 |
Why?
| | Prescription Drug Misuse | 1 | 2015 | 38 | 0.130 |
Why?
| | Health Status Indicators | 2 | 2012 | 154 | 0.130 |
Why?
| | Delivery of Health Care | 4 | 2023 | 869 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1244 | 0.130 |
Why?
| | Propylamines | 1 | 2014 | 12 | 0.130 |
Why?
| | Thalamus | 1 | 2015 | 80 | 0.130 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2014 | 13 | 0.130 |
Why?
| | Burnout, Professional | 1 | 2020 | 330 | 0.130 |
Why?
| | Mood Disorders | 1 | 2015 | 119 | 0.120 |
Why?
| | Biomedical Research | 1 | 2020 | 612 | 0.120 |
Why?
| | Analgesics | 1 | 2015 | 159 | 0.120 |
Why?
| | Cross-Cultural Comparison | 1 | 2014 | 81 | 0.120 |
Why?
| | Forecasting | 1 | 2016 | 354 | 0.120 |
Why?
| | Interviews as Topic | 4 | 2018 | 599 | 0.120 |
Why?
| | Cerebellum | 1 | 2015 | 203 | 0.120 |
Why?
| | Forensic Psychiatry | 1 | 2013 | 26 | 0.120 |
Why?
| | Australia | 1 | 2014 | 212 | 0.120 |
Why?
| | Self Concept | 1 | 2015 | 215 | 0.120 |
Why?
| | Employment | 1 | 2014 | 135 | 0.120 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2019 | 456 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2017 | 610 | 0.110 |
Why?
| | Seroepidemiologic Studies | 3 | 2019 | 146 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2011 | 525 | 0.110 |
Why?
| | Stress Disorders, Traumatic | 1 | 2013 | 24 | 0.110 |
Why?
| | Sex | 1 | 2012 | 3 | 0.110 |
Why?
| | Linear Models | 3 | 2010 | 827 | 0.110 |
Why?
| | Coronary Artery Disease | 1 | 2019 | 648 | 0.110 |
Why?
| | Social Stigma | 1 | 2013 | 87 | 0.110 |
Why?
| | Multivariate Analysis | 2 | 2019 | 1474 | 0.110 |
Why?
| | Infant | 2 | 2022 | 8295 | 0.110 |
Why?
| | Computer Communication Networks | 1 | 2012 | 33 | 0.110 |
Why?
| | Football | 1 | 2013 | 89 | 0.110 |
Why?
| | Advisory Committees | 1 | 2013 | 212 | 0.110 |
Why?
| | Algorithms | 3 | 2019 | 1543 | 0.100 |
Why?
| | Decision Making | 2 | 2017 | 809 | 0.100 |
Why?
| | Reproductive Health | 2 | 2023 | 68 | 0.100 |
Why?
| | Task Performance and Analysis | 2 | 2017 | 164 | 0.100 |
Why?
| | Sex Factors | 4 | 2019 | 1781 | 0.100 |
Why?
| | Walking | 1 | 2015 | 416 | 0.100 |
Why?
| | Therapy, Computer-Assisted | 1 | 2012 | 60 | 0.100 |
Why?
| | Statistics, Nonparametric | 2 | 2009 | 403 | 0.100 |
Why?
| | Information Dissemination | 1 | 2013 | 210 | 0.100 |
Why?
| | Interprofessional Relations | 1 | 2013 | 262 | 0.100 |
Why?
| | Prognosis | 2 | 2017 | 3443 | 0.100 |
Why?
| | United States Department of Defense | 1 | 2011 | 15 | 0.100 |
Why?
| | Consciousness Disorders | 1 | 2011 | 20 | 0.100 |
Why?
| | Child | 4 | 2023 | 19137 | 0.100 |
Why?
| | Ethics, Professional | 1 | 2011 | 15 | 0.100 |
Why?
| | Life Change Events | 1 | 2012 | 134 | 0.100 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 90 | 0.100 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 1868 | 0.100 |
Why?
| | Multiple Sclerosis | 1 | 2015 | 384 | 0.090 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 366 | 0.090 |
Why?
| | Health Policy | 1 | 2013 | 333 | 0.090 |
Why?
| | Brain | 3 | 2021 | 2490 | 0.090 |
Why?
| | Psychomotor Agitation | 1 | 2011 | 71 | 0.090 |
Why?
| | Inservice Training | 1 | 2011 | 106 | 0.090 |
Why?
| | Life Style | 1 | 2012 | 431 | 0.090 |
Why?
| | Glucose | 1 | 2015 | 954 | 0.090 |
Why?
| | Health Plan Implementation | 1 | 2011 | 133 | 0.090 |
Why?
| | Research | 1 | 2013 | 411 | 0.090 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 191 | 0.090 |
Why?
| | HIV-1 | 1 | 2015 | 776 | 0.090 |
Why?
| | Elective Surgical Procedures | 1 | 2011 | 160 | 0.090 |
Why?
| | Explosions | 1 | 2009 | 10 | 0.090 |
Why?
| | Irritable Mood | 2 | 2021 | 51 | 0.090 |
Why?
| | Religion and Psychology | 1 | 2009 | 26 | 0.090 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1384 | 0.090 |
Why?
| | Analysis of Variance | 2 | 2011 | 1295 | 0.090 |
Why?
| | Affective Symptoms | 1 | 2009 | 50 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2014 | 699 | 0.090 |
Why?
| | Data Collection | 1 | 2012 | 658 | 0.080 |
Why?
| | Alcohol Drinking | 1 | 2014 | 652 | 0.080 |
Why?
| | Neurologic Examination | 1 | 2009 | 126 | 0.080 |
Why?
| | Hypogonadism | 1 | 2009 | 77 | 0.080 |
Why?
| | Cooperative Behavior | 1 | 2011 | 408 | 0.080 |
Why?
| | Resilience, Psychological | 1 | 2009 | 97 | 0.080 |
Why?
| | Population Surveillance | 1 | 2011 | 413 | 0.080 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1125 | 0.080 |
Why?
| | Needs Assessment | 1 | 2009 | 327 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2011 | 364 | 0.080 |
Why?
| | Brain Mapping | 1 | 2011 | 532 | 0.070 |
Why?
| | Glasgow Coma Scale | 3 | 2014 | 150 | 0.070 |
Why?
| | Language Disorders | 1 | 2007 | 32 | 0.070 |
Why?
| | Aging | 1 | 2017 | 1677 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 827 | 0.070 |
Why?
| | Psychological Tests | 1 | 2007 | 129 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2014 | 1185 | 0.070 |
Why?
| | Healthy Volunteers | 2 | 2018 | 201 | 0.070 |
Why?
| | Animals | 5 | 2018 | 33399 | 0.070 |
Why?
| | Machine Learning | 2 | 2021 | 331 | 0.070 |
Why?
| | Testosterone | 1 | 2009 | 351 | 0.070 |
Why?
| | Length of Stay | 1 | 2009 | 1031 | 0.060 |
Why?
| | Cognition | 2 | 2022 | 1025 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1390 | 0.060 |
Why?
| | Asphyxia | 1 | 2023 | 22 | 0.060 |
Why?
| | Guam | 1 | 2023 | 7 | 0.060 |
Why?
| | Friends | 1 | 2023 | 49 | 0.060 |
Why?
| | Immunoglobulin M | 1 | 2024 | 253 | 0.050 |
Why?
| | Stillbirth | 1 | 2022 | 58 | 0.050 |
Why?
| | Anxiety | 2 | 2020 | 846 | 0.050 |
Why?
| | Hawaii | 1 | 2022 | 36 | 0.050 |
Why?
| | Ownership | 1 | 2022 | 79 | 0.050 |
Why?
| | Public Opinion | 1 | 2022 | 59 | 0.050 |
Why?
| | Remission Induction | 1 | 2022 | 247 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2011 | 2235 | 0.050 |
Why?
| | Pharmacogenetics | 1 | 2022 | 151 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2023 | 331 | 0.050 |
Why?
| | Nursing Homes | 1 | 2022 | 130 | 0.050 |
Why?
| | Research Report | 1 | 2021 | 75 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2012 | 1965 | 0.050 |
Why?
| | Cathelicidins | 1 | 2020 | 39 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2015 | 1687 | 0.050 |
Why?
| | Lithium Compounds | 1 | 2019 | 10 | 0.040 |
Why?
| | Crisis Intervention | 1 | 2019 | 25 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2022 | 277 | 0.040 |
Why?
| | Central Nervous System | 1 | 2021 | 245 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 78 | 0.040 |
Why?
| | September 11 Terrorist Attacks | 1 | 2019 | 22 | 0.040 |
Why?
| | Disease Progression | 2 | 2017 | 2490 | 0.040 |
Why?
| | Retirement | 1 | 2019 | 29 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 128 | 0.040 |
Why?
| | Research Design | 2 | 2015 | 969 | 0.040 |
Why?
| | Patient Preference | 1 | 2020 | 170 | 0.040 |
Why?
| | Ketamine | 1 | 2019 | 93 | 0.040 |
Why?
| | Serologic Tests | 1 | 2018 | 52 | 0.040 |
Why?
| | Attitude | 1 | 2020 | 231 | 0.040 |
Why?
| | Germany | 1 | 2018 | 89 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 539 | 0.040 |
Why?
| | Memory Disorders | 1 | 2019 | 168 | 0.040 |
Why?
| | Nutrition Surveys | 1 | 2019 | 233 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2009 | 3175 | 0.040 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2019 | 118 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2022 | 648 | 0.040 |
Why?
| | Seasons | 1 | 2020 | 462 | 0.040 |
Why?
| | Behavior Therapy | 1 | 2019 | 237 | 0.040 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2016 | 44 | 0.040 |
Why?
| | RNA, Bacterial | 1 | 2017 | 175 | 0.040 |
Why?
| | Placenta | 1 | 2022 | 641 | 0.040 |
Why?
| | Organ Size | 1 | 2017 | 460 | 0.040 |
Why?
| | War-Related Injuries | 1 | 2017 | 33 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 490 | 0.030 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2017 | 314 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1167 | 0.030 |
Why?
| | Dopamine | 1 | 2018 | 249 | 0.030 |
Why?
| | Poverty | 1 | 2019 | 444 | 0.030 |
Why?
| | Reward | 1 | 2017 | 209 | 0.030 |
Why?
| | Psychological Techniques | 1 | 2014 | 8 | 0.030 |
Why?
| | Environment | 1 | 2017 | 346 | 0.030 |
Why?
| | Atomoxetine Hydrochloride | 1 | 2014 | 4 | 0.030 |
Why?
| | Florida | 1 | 2014 | 73 | 0.030 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2015 | 131 | 0.030 |
Why?
| | Community Mental Health Services | 1 | 2015 | 83 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1492 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2015 | 194 | 0.030 |
Why?
| | Risk-Taking | 1 | 2017 | 319 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 934 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 298 | 0.030 |
Why?
| | Health Surveys | 1 | 2015 | 454 | 0.030 |
Why?
| | Focus Groups | 1 | 2015 | 387 | 0.030 |
Why?
| | Biomarkers | 1 | 2024 | 3590 | 0.030 |
Why?
| | Personality | 1 | 2014 | 115 | 0.030 |
Why?
| | Exercise Test | 1 | 2015 | 551 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1323 | 0.030 |
Why?
| | Bacteria | 1 | 2019 | 757 | 0.030 |
Why?
| | Suramin | 1 | 2012 | 6 | 0.030 |
Why?
| | Pain Measurement | 1 | 2015 | 469 | 0.030 |
Why?
| | Leukopenia | 1 | 2012 | 27 | 0.030 |
Why?
| | Taxoids | 1 | 2012 | 98 | 0.030 |
Why?
| | Health Priorities | 1 | 2012 | 34 | 0.030 |
Why?
| | Nausea | 1 | 2012 | 107 | 0.030 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2012 | 91 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2012 | 307 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2022 | 5256 | 0.030 |
Why?
| | Phenotype | 1 | 2020 | 3004 | 0.030 |
Why?
| | Ethical Review | 1 | 2011 | 3 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 195 | 0.020 |
Why?
| | Wheelchairs | 1 | 2011 | 16 | 0.020 |
Why?
| | Personal Satisfaction | 1 | 2012 | 188 | 0.020 |
Why?
| | Personal Autonomy | 1 | 2011 | 41 | 0.020 |
Why?
| | Dementia | 1 | 2013 | 208 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 5694 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 649 | 0.020 |
Why?
| | Age Distribution | 1 | 2011 | 362 | 0.020 |
Why?
| | Medical History Taking | 1 | 2010 | 120 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 736 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2012 | 544 | 0.020 |
Why?
| | Reference Values | 1 | 2011 | 775 | 0.020 |
Why?
| | Geriatric Assessment | 1 | 2011 | 185 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2009 | 57 | 0.020 |
Why?
| | Pain | 1 | 2015 | 736 | 0.020 |
Why?
| | Rehabilitation Centers | 1 | 2009 | 34 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2009 | 115 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2011 | 528 | 0.020 |
Why?
| | Self Efficacy | 1 | 2012 | 366 | 0.020 |
Why?
| | Preoperative Care | 1 | 2011 | 332 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 1947 | 0.020 |
Why?
| | ROC Curve | 1 | 2009 | 473 | 0.020 |
Why?
| | Health Status | 1 | 2012 | 726 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1720 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2009 | 355 | 0.020 |
Why?
| | Physician-Patient Relations | 1 | 2011 | 489 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1440 | 0.020 |
Why?
| | Mice | 1 | 2016 | 15528 | 0.010 |
Why?
|
|
Brenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|